Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Key concepts
- Glossary of terms
- Alcohol-associated mortality
- Alcohol-related liver deaths in the UK
- Price of alcohol to income ratio & consumption
- Consequences of excess alcohol consumption
- Alcoholism is a clandestine disorder
- Subjects with alcohol dependence
- CAGE questions
- Factors of development of alcoholic liver disease
- Histology of alcoholic liver disease
- The mechanism of alcoholic liver disease
- How strong is the urge to drink alcohol?
- Divert study
- Does abstinence matter?
- Survival and alcohol use vs. abstinence
- Psychotherapy for alcoholism
- Pharmacotherapy of alcoholism
- Pharmacotherapy for alcoholic hepatitis (1)
- Survival in three randomized controlled trials
- Pharmacotherapy for alcoholic hepatitis (2)
- Pentoxifylline improves short-term survival
- Infliximab in severe alcoholic hepatitis
- Etanercept and alcoholic hepatitis
- Liver transplantation in severe alcoholic hepatitis
- Pharmacotherapy for alcoholic fibrosis/cirrhosis
- Decompensated alcoholic liver disease
- Survival after liver transplantation
- Prognostic factors for increased risk of relapse
- Does relapse matter?
- Consequences of relapse after transplantation
- Key concepts - summary
Topics Covered
- Alcoholism, including the toll of alcoholism, is key to understanding alcoholic liver disease (ALD)
- Alcoholism is clandestine disorder
- Abstinence is key to recovery from both alcoholism and ALD
- There are few evidence-based therapies for ALD, other than abstinence
- Liver transplantation is valuable in selected subjects with ALD
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Lucey, M. (2011, January 5). Alcoholic liver disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/QQGY9647.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Michael Lucey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.